POT1 and central nervous system cancer: Next generation sequencing of a wide variety of cancers, including melanoma, chronic lymphocytic leukemia, angiosarcomas and gliomas, has identified recurrent somatic mutations in hPOT1, suggesting that hPOT1 functions as an important tumor suppressor (25,26).